A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs
Tóm tắt
Từ khóa
Tài liệu tham khảo
Da Rocha, 2001, Natural products in anticancer therapy, Curr Opin Pharmacol, 1, 364, 10.1016/S1471-4892(01)00063-7
Imanshahidi, 2008, Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine, Phytother Res, 22, 999, 10.1002/ptr.2399
Singhal, 1976, Anthelmintic activity of berberine hydrochloride against Syphacia obvelata in mice, Indian J Exp Biol, 14, 345
Satou, 2002, Inhibitory effect of isoquinoline alkaloids on movement of second-stage larvae of Toxocara canis, Biol Pharm Bull, 25, 1651, 10.1248/bpb.25.1651
Kuo, 2004, The anti-inflammatory potential of berberine in vitro and in vivo, Cancer Lett, 203, 127, 10.1016/j.canlet.2003.09.002
Franzblau, 1986, Comparative in vitro antimicrobial activity of Chinese medicinal herbs, J Ethnopharmacol, 15, 279, 10.1016/0378-8741(86)90166-2
Zhang, 1997, A study of Helicobacterium pylori and prevention and treatment of chronic atrophic gastritis, J Tradit Chin Med, 17, 3
Yang, 1996, In vitro response of Blastocystis hominis against traditional Chinese medicine, J Ethnopharmacol, 55, 35, 10.1016/S0378-8741(96)01471-7
Mahady, 2003, In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis, Phytother Res, 17, 217, 10.1002/ptr.1108
Romero, 2005, Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an ‘in vitro’ replicative system, Antiviral Res, 68, 75, 10.1016/j.antiviral.2005.07.005
Li, 2008, Alkaloids from Corydalis saxicola and their anti-hepatitis B virus activity, Chem Biodivers, 5, 777, 10.1002/cbdv.200890074
Ferreira, 2008, Helicobacter and gastric malignancies, Helicobacter, 13, 28, 10.1111/j.1523-5378.2008.00633.x
Farinati, 2008, Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway, Eur J Cancer Prev, 17, 195, 10.1097/CEJ.0b013e3282f0bff5
Wang, 1987, Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas, Cancer Res, 47, 4192
Chang, 1990, Berberine-induced morphologic differentiation and down- regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells, Cancer Lett, 55, 103, 10.1016/0304-3835(90)90018-S
Chang, 1991, Down-regulation of c-Ki-ras2 gene expression associated with morphologic differentiation in human embryonal carcinoma cells treated with berberine, J Formos Med Assoc, 90, 10
Liang, 2008, Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells, Eur J Pharmacol, 590, 343, 10.1016/j.ejphar.2008.06.034
Katiyar, 2009, p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo, Mol Carcinog, 47, 24, 10.1002/mc.20453
Shen, 2005, Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents, Antioxid Redox Signal, 7, 1648, 10.1089/ars.2005.7.1648
Fukuda, 1999, Inhibition of activator protein 1 activity by berberine in human hepatoma cells, Planta Med, 65, 381, 10.1055/s-2006-960795
Pandey, 2008, Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis, Cancer Res, 68, 5370, 10.1158/0008-5472.CAN-08-0511
Mantena, 2006, Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP, Carcinogenesis, 27, 2018, 10.1093/carcin/bgl043
Letasiova, 2006, Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells, Cancer Lett, 239, 254, 10.1016/j.canlet.2005.08.024
Wu, 1999, Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity, Int J Cancer, 81, 923, 10.1002/(SICI)1097-0215(19990611)81:6<923::AID-IJC14>3.0.CO;2-D
Rungsitiyakorn, 1981, On the pH dependence of binding of berberine to DNA, J Pharm Pharmacol, 33, 125, 10.1111/j.2042-7158.1981.tb13732.x
Creasey, 1979, Biochemical effects of berberine, Biochem Pharmacol, 28, 1081, 10.1016/0006-2952(79)90308-3
Islam, 2008, RNA targeting by small molecule alkaloids: studies on the binding of berberine and palmatine to polyribonucleotides and comparison to ethidium, J Mol Struct, 875, 382, 10.1016/j.molstruc.2007.05.004
Serafim, 2008, Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line, Cancer Chemother Pharmacol, 61, 1007, 10.1007/s00280-007-0558-9
Xia, 2007, Study of the interactions of berberine and daunorubicin with DNA using alternating penalty trilinear decomposition algorithm combined with excitation-emission matrix fluorescence data, Talanta, 73, 606, 10.1016/j.talanta.2007.04.020
Bhadra, 2008, Berberine-DNA complexation: new insights into the cooperative binding and energetic aspects, Biochim Biophys Acta Gen Subj, 1780, 1054, 10.1016/j.bbagen.2008.05.005
Islam, 2008, Binding of DNA-binding alkaloids berberine and palmatine to tRNA and comparison to ethidium: spectroscopic and molecular modeling studies, J Mol Struct, 891, 498, 10.1016/j.molstruc.2008.04.043
Islam, 2007, RNA binding small molecules: studies on t-RNA binding by cytotoxic plant alkaloids berberine, palmatine and the comparison to ethidium, Biophys Chem, 125, 508, 10.1016/j.bpc.2006.11.001
Tian, 2008, Interaction of anticancer herbal drug berberine with DNA immobilized on the glassy carbon electrode, Bioelectrochemistry, 73, 18, 10.1016/j.bioelechem.2008.02.005
Liu, 2009, Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage, Mutat Res, 662, 75, 10.1016/j.mrfmmm.2008.12.009
Weber, 1985, N-acetylation pharmacogenetics, Pharmacol Rev, 37, 25
Butcher, 2008, Regulation of arylamine N-acetyltransferases, Curr Drug Metab, 9, 498, 10.2174/138920008784892128
Sim, 2003, Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function, Biochem Soc Trans, 31, 615, 10.1042/bst0310615
Chung, 1999, Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells, Food Chem Toxicol, 37, 319, 10.1016/S0278-6915(99)00016-2
Lin, 1999, Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells, Am J Chin Med, 27, 265, 10.1142/S0192415X99000306
Chung, 2000, Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells, Am J Chin Med, 28, 227, 10.1142/S0192415X00000271
Wang, 2002, Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells, Neurochem Res, 27, 883, 10.1023/A:1020335430016
Misra, 2008, Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer, Connect Tissue Res, 49, 219, 10.1080/03008200802143356
Lin, 2005, Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells, Phytomedicine, 12, 351, 10.1016/j.phymed.2003.11.008
Rundhaug, 2008, Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis, Photochem Photobiol, 84, 322, 10.1111/j.1751-1097.2007.00261.x
Aparicio Gallego, 2007, Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer, Clin Transl Oncol, 9, 694, 10.1007/s12094-007-0126-0
Breinig, 2007, Cyclooxygenase-2 (COX-2) – a therapeutic target in liver cancer?, Curr Pharm Des, 13, 3305, 10.2174/138161207782360627
Patel, 2007, Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer, Indian J Biochem Biophys, 44, 419
Sarkar, 2007, Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy, Mini Rev Med Chem, 7, 599, 10.2174/138955707780859431
Singh-Ranger, 2008, The role of cyclooxygenase-2 in breast cancer: review, Breast Cancer Res Treat, 109, 189, 10.1007/s10549-007-9641-5
Fukuda, 1999, Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells, J Ethnopharmacol, 66, 227, 10.1016/S0378-8741(98)00162-7
Kuo, 2005, Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells, In Vivo, 19, 247
Liu, 2009, Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells, Biochem Biophys Res Commun, 378, 174, 10.1016/j.bbrc.2008.10.169
Seaver, 2004, Inhibition of COX isoforms by nutraceuticals, J Herb Pharmacother, 4, 11, 10.1080/J157v04n02_02
Shay, 2008, Targeting telomerase for cancer therapeutics, Br J Cancer, 98, 677, 10.1038/sj.bjc.6604209
Biao, 2007, Study the ef fect of berber ine on the telomerase activity of human nasopharyngeal carcinoma (NPC) CNE-2, Shanxi Med J, 36, 1281
Sriwilaijareon, 2002, Stage specificity of Plasmodium falciparum telomerase and its inhibition by berberine, Parasitol Int, 51, 99, 10.1016/S1383-5769(01)00092-7
Makhey, 1996, Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons, Bioorg Med Chem, 4, 781, 10.1016/0968-0896(96)00054-5
Kim, 1998, Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine, Biochemistry, 37, 16316, 10.1021/bi9810961
Mantena, 2006, Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells, Mol Cancer Ther, 5, 296, 10.1158/1535-7163.MCT-05-0448
Kettmann, 2004, Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model, J Comput Aided Mol Des, 18, 785, 10.1007/s10822-004-7878-1
Kobayashi, 1995, Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes, Planta Med, 61, 414, 10.1055/s-2006-958127
Wang, 1996, Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne, Chem Res Toxicol, 9, 75, 10.1021/tx950080y
Li, 2000, Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug- enzyme interactions, Biochemistry, 39, 7107, 10.1021/bi000171g
Kang, 2002, Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine, Mol Pharmacol, 61, 879, 10.1124/mol.61.4.879
Qin, 2007, Inhibition of DNA topoisomerase I by natural and synthetic mono- and dimeric protoberberine alkaloids, Chem Biodivers, 4, 481, 10.1002/cbdv.200790040
Jantova, 2003, Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells, J Pharm Pharmacol, 55, 1143, 10.1211/002235703322277186
Jantova, 2007, Berberine induces apoptosis through a mitochondrial/ caspase pathway in human promonocytic U937 cells, Toxicol In Vitro, 21, 25, 10.1016/j.tiv.2006.07.015
Lin, 2006, Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line, World J Gastroenterol, 12, 21, 10.3748/wjg.v12.i1.21
Wang, 2008, Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine, Phytomedicine, 15, 1062, 10.1016/j.phymed.2008.05.002
Kim, 2008, Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells, Planta Med, 74, 1693, 10.1055/s-0028-1088313
Lin, 2004, Berberine inhibits HIF-1alpha expression via enhanced proteolysis, Mol Pharmacol, 66, 612
Lin, 2008, Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide, BMC Cancer, 8, 58, 10.1186/1471-2407-8-58
Lee, 2006, Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model, Atherosclerosis, 186, 29, 10.1016/j.atherosclerosis.2005.06.048
Kim, 2008, Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes, Phytomedicine, 15, 340, 10.1016/j.phymed.2007.09.011
Letasiova, 2005, Antiproliferative activity of berberine in vitro and in vivo, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 149, 461, 10.5507/bp.2005.080
Li, 2008, Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells, Biomed Pharmacother, 62, 573, 10.1016/j.biopha.2008.08.003
Yount, 2004, Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro, J Exp Ther Oncol, 4, 137
Issat, 2006, Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway, Oncol Rep, 16, 1273
Szeto, 2002, Characterization of berberine on human cancer cells in culture, Turk J Med Sci, 32, 363
Letasiova, 2006, Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells, J Pharm Pharmacol, 58, 263, 10.1211/jpp.58.2.0015
Chi, 1994, Flowcytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells, Life Sci, 54, 2099, 10.1016/0024-3205(94)00719-5
Hwang, 2002, Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver, Arch Toxicol, 76, 664, 10.1007/s00204-002-0351-9
Peng, 2006, Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2, Toxicol Appl Pharmacol, 214, 8, 10.1016/j.taap.2005.11.010
Mitani, 2001, Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma, Cancer Lett, 165, 35, 10.1016/S0304-3835(00)00710-2
Iizuka, 2000, Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines, Cancer Lett, 148, 19, 10.1016/S0304-3835(99)00264-5
Wu, 1998, Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells, Life Sci, 62, 2283, 10.1016/S0024-3205(98)00209-4
Tan, 2006, Investigation of differentially expressed proteins due to the inhibitory effects of berberine in human liver cancer cell line HepG2, Mol Biosyst, 2, 250, 10.1039/b517116d
Pereira, 2007, Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions, J Pharmacol Exp Ther, 323, 636, 10.1124/jpet.107.128017
Jantova, 2006, Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells, J Photochem Photobiol B, 85, 163, 10.1016/j.jphotobiol.2006.07.001
Orfila, 2000, Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro, J Ethnopharmacol, 71, 449, 10.1016/S0378-8741(00)00177-X
Ko, 2000, Vasorelaxant and antiproliferative effects of berberine, Eur J Pharmacol, 399, 187, 10.1016/S0014-2999(00)00339-3
Lin, 2004, Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth, Clin Exp Pharmacol Physiol, 31, 65, 10.1111/j.1440-1681.2004.03951.x
Anis, 1999, Role of berberine as an adjuvant response modifier during tumour therapy in mice, Pharm Pharmacol Commun, 5, 697, 10.1211/146080899128734415
Yang, 1996, Dose-dependent effects of berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells, Naunyn Schmiedebergs Arch Pharmacol, 354, 102, 10.1007/BF00178709
Sethi, 1983, Enzyme inhibition VI: inhibition of reverse transcriptase activity by protoberberine alkaloids and structure-activity relationships, J Pharm Sci, 72, 538, 10.1002/jps.2600720515
Weber, 2003, Chemical comparison of goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers, J Agric Food Chem, 51, 7352, 10.1021/jf034339r
Lin, 2006, Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle, Anticancer Res, 26, 1097
Lin, 2007, Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway, Anticancer Res, 27, 3371
Eom, 2008, Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway, Biol Pharm Bull, 31, 558, 10.1248/bpb.31.558
Yokozawa, 2005, Protective role of Coptidis Rhizoma alkaloids against peroxynitrite-induced damage to renal tubular epithelial cells, J Pharm Pharmacol, 57, 367, 10.1211/0022357055470
Li, 2000, Huanglian, A chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells, Mol Pharmacol, 58, 1287, 10.1124/mol.58.6.1287
Hsu, 2007, Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38MAPK and FasL, Arch Toxicol, 81, 719, 10.1007/s00204-006-0169-y
Bremer, 2006, Targeted induction of apoptosis for cancer therapy: current progress and prospects, Trends Mol Med, 12, 382, 10.1016/j.molmed.2006.06.002
Kuo, 1995, Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells, Cancer Lett, 93, 193, 10.1016/0304-3835(95)03809-B
Lin, 2006, Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3, Anticancer Res, 26, 227
Hwang, 2006, Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells, Arch Toxicol, 80, 62, 10.1007/s00204-005-0014-8
Piyanuch, 2007, Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells, Cancer Lett, 258, 230, 10.1016/j.canlet.2007.09.007
Choi, 2009, Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells, Int J Oncol, 34, 1221
Choi, 2008, Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis, Anticancer Res, 28, 3777
Lin, 2007, GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells, Anticancer Res, 27, 3379
Irani, 2000, Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling, Circ Res, 87, 179, 10.1161/01.RES.87.3.179
Vavreckova, 1996, Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism, Planta Med, 62, 397, 10.1055/s-2006-957924
Hsieh, 2007, Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells, J Agric Food Chem, 55, 10437, 10.1021/jf071868c
Liu, 2008, Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose, Arch Biochem Biophys, 475, 128, 10.1016/j.abb.2008.04.022
Tan, 2007, Antioxidant properties of berberine on cultured rabbit corpus cavernosum smooth muscle cells injured by hydrogen peroxide, Acta Pharmacol Sin, 28, 1914, 10.1111/j.1745-7254.2007.00705.x
Yokozawa, 2004, Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components, J Pharm Pharmacol, 56, 547, 10.1211/0022357023024
Liu, 2008, Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase, Chin Med J (Engl), 121, 706, 10.1097/00029330-200804020-00009
Jang, 2009, Hydroxyl radical scavenging activities of isoquinoline alkaloids isolated from Coptis Chinensis, Arch Pharm Res, 32, 341, 10.1007/s12272-009-1305-z
Meeran, 2008, Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation, Toxicol Appl Pharmacol, 229, 33, 10.1016/j.taap.2007.12.027
Enk, 2007, Differential effect of Rhizoma coptidis and its main alkaloid compound berberine on TNF-alpha induced NFkappaB translocation in human keratinocytes, J Ethnopharmacol, 109, 170, 10.1016/j.jep.2006.07.013
Lee, 2007, Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells, Pharmacol Res, 56, 193, 10.1016/j.phrs.2007.06.003
Hu, 2008, Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways, Eur J Pharmacol, 580, 70, 10.1016/j.ejphar.2007.11.013
Wartenberg, 2003, Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional chinese medicine, Lab Invest, 83, 87, 10.1097/01.LAB.0000049348.51663.2F
Lin, 2008, Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro, In Vivo, 22, 223
Kim, 2008, Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts, Phytomedicine, 15, 749, 10.1016/j.phymed.2007.11.004
Matsuo, 2007, Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells, Cancer Lett, 251, 288, 10.1016/j.canlet.2006.11.027
Ho, 2009, Berberine suppresses in vitro migration and invasion of human Scc-4 tongue squamous cancer cells through the inhibitions of Fak, Ikk, Nf-Kappab, U-Pa and Mmp-2 and -9, Cancer Lett, 279, 155, 10.1016/j.canlet.2009.01.033
Liu, 2008, Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma, Br J Cancer, 98, 363, 10.1038/sj.bjc.6604167
Yoshino, 1998, Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis, Br J Cancer, 78, 833, 10.1038/bjc.1998.588
Ichiki, 2000, Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer, Clin Exp Metastasis, 18, 539, 10.1023/A:1011980313237
Sharom, 2008, ABC multidrug transporters: structure, function and role in chemoresistance, Pharmacogenomics, 9, 105, 10.2217/14622416.9.1.105
Velamakanni, 2007, ABCG transporters: structure, substrate specificities and physiological roles: a brief overview, J Bioenerg Biomembr, 39, 465, 10.1007/s10863-007-9122-x
Sakai, 2002, Characterization of berberine transport into Coptis japonica cells and the involvement of ABC protein, J Exp Bot, 53, 1879, 10.1093/jxb/erf052
Lin, 1999, Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel, Br J Cancer, 81, 416, 10.1038/sj.bjc.6690710
Lin, 1999, Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells, Cancer, 85, 1937, 10.1002/(SICI)1097-0142(19990501)85:9<1937::AID-CNCR9>3.0.CO;2-F
Shvarev, 1972, Anti-blastic properties of berberine and its derivatives, Farmakol Toksikol, 35, 73
Hoshi, 1976, Antitumor activity of berberrubine derivatives, Gann, 67, 321
Nishino, 1986, Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin, Oncology, 43, 131, 10.1159/000226349
Anis, 2001, Inhibition of chemical carcinogenesis by berberine in rats and mice, J Pharm Pharmacol, 53, 763, 10.1211/0022357011775901
Zhang, 1990, Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors, Chin Med J (Engl), 103, 658
Jagetia, 2004, Effect of Alstonia scholaris in enhancing the anticancer activity of berberine in the Ehrlich ascites carcinoma-bearing mice, J Med Food, 7, 235, 10.1089/1096620041224094
Peng, 2008, Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death, Int J Radiat Oncol Biol Phys, 70, 529, 10.1016/j.ijrobp.2007.08.034
Fukutake, 1998, Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon, Biol Pharm Bull, 21, 814, 10.1248/bpb.21.814
Thirupurasundari, 2009, Effect of berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats, Chem Biol Interact, 177, 190, 10.1016/j.cbi.2008.09.027
Iizuka, 2000, Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6, Cancer Lett, 158, 35, 10.1016/S0304-3835(00)00496-1
Iizuka, 2002, Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma, Int J Cancer, 99, 286, 10.1002/ijc.10338
Ho, 2009, Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model, Phytomedicine, 16, 887, 10.1016/j.phymed.2009.02.015
Harikumar, 2008, Inhibition of progression of erythroleukemia induced by Friend virus in Balb/C mice by natural products-berberine, curcumin and picroliv, J Exp Ther Oncol, 7, 275